The overall aims of this project were to identify rnRNAs overexpressed or underexpressed as MCF7 human breast cancer cells progress to growth pathways independent of oestrogen and resistant to the antioestrogen, fulvestrant. Growth of oestrogen maintained and long-term oestrogen deprived MCF7,cells with or without la-8M l7p-oestradiol for 7 days enabled the comparison of expression profiles to identify a number of oestrogen regulated genes, in addition to a number of genes differentially expressed in long-term oestrogen deprived cells compared to cells which had been deprived of oestrogen for just? days. Comparison of expression profiles for oestrogen maintained and oestrogen deprived cells following long-term exposure to fulvestrant reveal...
Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a common o...
<div><p>Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a ...
Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of breast tumors...
Background Endocrine resistance is a major hurdle in breast cancer management, and determining the u...
Despite the benefit tamoxifen has provided for millions of breast cancer patients worldwide, almost ...
Over the years, the MCF7 human breast cancer cell line has provided a model system for the study of ...
Breast cancer accounts as the most prevalent cancer and the leading cause of cancer death worldwide ...
Although endocrine treatment of breast cancer is effective and common practice, in advanced disease ...
Antiestrogens, such as tamoxifen, are widely used for endocrine treatment of estrogen receptor–posit...
Prolonged endocrine therapy is the mainstay of treatment for ER+ breast cancer patients. However, re...
Antiestrogens, such as tamoxifen, are widely used for endocrine treatment of estrogen receptor-posit...
Endocrine treatment has had a groundbreaking contribution to the decline in breast cancer mortality....
BACKGROUND: Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast ca...
BACKGROUND: Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast ca...
Resistance to tamoxifen, Faslodex and oestrogen-deprivation represents a major hurdle in breast canc...
Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a common o...
<div><p>Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a ...
Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of breast tumors...
Background Endocrine resistance is a major hurdle in breast cancer management, and determining the u...
Despite the benefit tamoxifen has provided for millions of breast cancer patients worldwide, almost ...
Over the years, the MCF7 human breast cancer cell line has provided a model system for the study of ...
Breast cancer accounts as the most prevalent cancer and the leading cause of cancer death worldwide ...
Although endocrine treatment of breast cancer is effective and common practice, in advanced disease ...
Antiestrogens, such as tamoxifen, are widely used for endocrine treatment of estrogen receptor–posit...
Prolonged endocrine therapy is the mainstay of treatment for ER+ breast cancer patients. However, re...
Antiestrogens, such as tamoxifen, are widely used for endocrine treatment of estrogen receptor-posit...
Endocrine treatment has had a groundbreaking contribution to the decline in breast cancer mortality....
BACKGROUND: Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast ca...
BACKGROUND: Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast ca...
Resistance to tamoxifen, Faslodex and oestrogen-deprivation represents a major hurdle in breast canc...
Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a common o...
<div><p>Resistance to tamoxifen (Tam), a widely used antagonist of the estrogen receptor (ER), is a ...
Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of breast tumors...